Korro Bio, Inc. (KRRO) Debt Components
- 2023-09-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Basis Spread on Variable Ratepure (m).
- 2023-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Basis Spread on Variable Ratepure (m).
- 2023-03-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Basis Spread on Variable Ratepure 3 month · 9.25%.
- 2023-03-31: Long-term Debt, Current MaturitiesUSD $11.67M; Long-term Debt, Excluding Current MaturitiesUSD (m); Debt Instrument, Basis Spread on Variable Ratepure (m).
Korro Bio, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Debt Instrument, Basis Spread on Variable Rate pure |
|---|---|---|---|
| 2023-09-30 | $0.00 | (m) | (m) |
| 2023-06-30 | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | (m) | 3 month · 9.25% |
| 2023-03-31 | $11.67M | (m) | (m) |
| 2022-12-31 | $10.00M | (m) | (m) |
| 2022-12-31 | (m) | (m) | 12 month · 9.00% |
| 2022-09-30 | (m) | (m) | 9 month · 7.75% |
| 2022-09-30 | $8.33M | (m) | (m) |
| 2022-06-30 | (m) | (m) | 6 month · 6.25% |
| 2022-06-30 | $5.83M | (m) | (m) |
| 2022-03-31 | (m) | (m) | 3 month · 4.75% |
| 2022-03-31 | $3.33M | (m) | (m) |
| 2021-12-31 | $833.00K | (m) | (m) |
| 2021-12-31 | (m) | (m) | 12 month · 4.75% |
| 2021-09-30 | (m) | (m) | 9 month · 4.75% |
| 2019-12-31 | (m) | $180.00K | (m) |
| 2019-09-30 | (m) | $222.00K | (m) |
| 2018-12-31 | (m) | $349.00K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |